BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9374372)

  • 1. Deletion mapping on chromosome 17p in medulloblastoma.
    Steichen-Gersdorf E; Baumgartner M; Kreczy A; Maier H; Fink FM
    Br J Cancer; 1997; 76(10):1284-7. PubMed ID: 9374372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
    Emadian SM; McDonald JD; Gerken SC; Fults D
    Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
    Rood BR; Zhang H; Weitman DM; Cogen PH
    Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma.
    Kraus JA; Koch A; Albrecht S; Von Deimling A; Wiestler OD; Pietsch T
    Int J Cancer; 1996 Jul; 67(1):11-5. PubMed ID: 8690510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.
    Cogen PH; Daneshvar L; Metzger AK; Duyk G; Edwards MS; Sheffield VC
    Am J Hum Genet; 1992 Mar; 50(3):584-9. PubMed ID: 1347196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
    McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
    Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.
    Jung HL; Wang KC; Kim SK; Sung KW; Koo HH; Shin HY; Ahn HS; Shin HJ; Cho BK
    J Neurooncol; 2004; 67(1-2):41-6. PubMed ID: 15072446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.
    Albrecht S; von Deimling A; Pietsch T; Giangaspero F; Brandner S; Kleihues P; Wiestler OD
    Neuropathol Appl Neurobiol; 1994 Feb; 20(1):74-81. PubMed ID: 8208343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
    Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
    Gomes CC; Fonseca-Silva T; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.
    Dunn J; Garde J; Dolan K; Gosney JR; Sutton R; Meltzer SJ; Field JK
    Oncogene; 1999 Jan; 18(4):987-93. PubMed ID: 10023674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma.
    Scheurlen WG; Krauss J; Kühl J
    Int J Cancer; 1995 Nov; 63(3):372-4. PubMed ID: 7591234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor genes and medulloblastoma.
    Cogen PH; McDonald JD
    J Neurooncol; 1996 Jul; 29(1):103-12. PubMed ID: 8817421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion mapping of the medulloblastoma locus on chromosome 17p.
    Cogen PH; Daneshvar L; Metzger AK; Edwards MS
    Genomics; 1990 Oct; 8(2):279-85. PubMed ID: 1979050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.